Michael P. Cooke, Chief Scientific Officer at Magenta Therapeutics, Inc. (MGTA), sold 844 shares at $12.00 ($10K) on 2019-09-12, disclosed to the SEC on 2019-09-16.
Scheduled sale ($10k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| MGTA | SELL | 2019-11-01 | $53K | — | Filing → |
| MGTA | SELL | 2019-10-03 | $50K | — | Filing → |
| MGTA | SELL | 2019-09-19 | $20K | — | Filing → |